Breakthrough in Cancer Treatment: Russian Scientists Lead the Way
A groundbreaking oncological vaccine developed by Russian scientists has shown astonishing results in preclinical trials, as reported by Alexander Gintsburg, Director of the Gamaleya Research Institute of Epidemiology and Microbiology.
The vaccine, a result of cutting-edge research, is set to be tested on other types of cancer, with oncology institutes collaborating on further studies. This innovative approach could revolutionize cancer treatment, offering hope for millions worldwide.
Veronika Skvortsova, head of the Federal Medical-Biological Agency, announced that clinical use of the vaccine could begin as early as next year. During experiments on malignant intestinal adenocarcinoma in animals, the vaccine not only slowed tumor growth significantly but also reduced tumor volumes by 75–80%.
#science
A groundbreaking oncological vaccine developed by Russian scientists has shown astonishing results in preclinical trials, as reported by Alexander Gintsburg, Director of the Gamaleya Research Institute of Epidemiology and Microbiology.
“We’ve observed melanoma tumors completely dissolve during preclinical tests—not just the primary tumor but also metastases. I believe we may soon see its potential even in patients with Stage IV cancer.”
The vaccine, a result of cutting-edge research, is set to be tested on other types of cancer, with oncology institutes collaborating on further studies. This innovative approach could revolutionize cancer treatment, offering hope for millions worldwide.
Veronika Skvortsova, head of the Federal Medical-Biological Agency, announced that clinical use of the vaccine could begin as early as next year. During experiments on malignant intestinal adenocarcinoma in animals, the vaccine not only slowed tumor growth significantly but also reduced tumor volumes by 75–80%.
#science